GlassScriptPhysician profile
Kevin Hsiung
NPI 1255631313
$17,111.87
in general payments reported to CMS, 2019-2025
23 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $187 · 2021: $9,852 · 2022: $6,132 · 2023: $110 · 2024: $252 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $634.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $15,825.94 | 2021-2022 | |
| Abbvie INC. | $195.61 | 2019-2023 | |
| Hologic Sales and Service, LLC | $161.38 | 2024-2025 | Myosure Tissue Removal Device, Thinprep 2000 Processor |
| Daiichi Sankyo INC. | $146.23 | 2019-2024 | Injectafer |
| Coloplast Corp | $109.12 | 2024 | |
| Sage Therapeutics, LLC | $89.56 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $71.25 | 2019-2024 | |
| Coopersurgical, INC. | $66.41 | 2024-2025 | Onetrac Lx, Paragard T 380a, Summit Doppler |
| Allergan, INC. | $61.73 | 2019 | |
| Mayne Pharma Commercial LLC | $45.71 | 2022-2025 | |
| Minerva Surgical, INC | $42.27 | 2019-2023 | |
| Therapeuticsmd, INC. | $41.94 | 2020 | |
| Lupin INC. | $33.28 | 2019-2020 | |
| Astellas Pharma US INC | $32.64 | 2023 | Veozah |
| Organon LLC | $32.03 | 2022-2023 | Nexplanon |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $24.97 | 2023 | |
| Merck Sharp & Dohme LLC | $24.88 | 2019-2020 | |
| Avion Pharmaceuticals | $21.50 | 2020 | |
| Davol INC. | $20.73 | 2020 | |
| Medtronic, INC. | $19.63 | 2022 | |
| Ethicon US, LLC | $17.46 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.92 | 2025 | Qelbree |
| Myovant Sciences INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Hsiung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.